User profiles for Shawn P. Iadonato
Shawn IadonatoKineta Inc. Verified email at kineta.us Cited by 2320 |
Association of the FTO gene with BMI
…, Y Xin, CA Scherer, CL Magness, SP Iadonato… - …, 2008 - Wiley Online Library
Variants in the FTO gene have been strongly associated with obesity in a very large sample
(38,759) of diabetic and control subjects. To replicate these findings, the previously reported …
(38,759) of diabetic and control subjects. To replicate these findings, the previously reported …
Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain
…, DE Vetter, C Ghelardini, SP Iadonato… - Proceedings of the …, 2017 - National Acad Sciences
Opioids are first-line drugs for moderate to severe acute pain and cancer pain. However,
these medications are associated with severe side effects, and whether they are efficacious in …
these medications are associated with severe side effects, and whether they are efficacious in …
[HTML][HTML] Safety and pharmacodynamics of dalazatide, a Kv1. 3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial
…, D Peckham, EJ Muñoz-Elías, JG Kruger, SP Iadonato - PloS one, 2017 - journals.plos.org
Background Dalazatide is a specific inhibitor of the Kv1.3 potassium channel. The expression
and function of Kv1.3 channels are required for the function of chronically activated …
and function of Kv1.3 channels are required for the function of chronically activated …
Durable pharmacological responses from the peptide ShK-186, a specific Kv1. 3 channel inhibitor that suppresses T cell mediators of autoimmune disease
The Kv1.3 channel is a recognized target for pharmaceutical development to treat autoimmune
diseases and organ rejection. ShK-186, a specific peptide inhibitor of Kv1.3, has shown …
diseases and organ rejection. ShK-186, a specific peptide inhibitor of Kv1.3, has shown …
Extracellular 2′-5′ oligoadenylate synthetase stimulates RNase L-independent antiviral activity: a novel mechanism of virus-induced innate immunity
…, CA Scherer, M McVean, SP Iadonato… - Journal of …, 2010 - Am Soc Microbiol
The 2′-5′ oligoadenylate synthetase (OAS) proteins are traditionally considered
intracellular antiviral proteins. However, several studies demonstrate a correlation between the …
intracellular antiviral proteins. However, several studies demonstrate a correlation between the …
[HTML][HTML] Kv1. 3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases
…, JD Swarbrick, H Wulff, SP Iadonato… - The FASEB …, 2014 - ncbi.nlm.nih.gov
The voltage-gated potassium (Kv) 1.3 channel is widely regarded as a therapeutic target for
immunomodulation in autoimmune diseases. ShK-186, a selective inhibitor of Kv1. 3 …
immunomodulation in autoimmune diseases. ShK-186, a selective inhibitor of Kv1. 3 …
Targeting innate immunity for antiviral therapy through small molecule agonists of the RLR pathway
…, TW Geisbert, KM Bedard, SP Iadonato… - Journal of …, 2016 - Am Soc Microbiol
The cellular response to virus infection is initiated when pathogen recognition receptors (PRR)
engage viral pathogen-associated molecular patterns (PAMPs). This process results in …
engage viral pathogen-associated molecular patterns (PAMPs). This process results in …
[HTML][HTML] Analysis of the Macaca mulatta transcriptome and the sequence divergence between Macaca and human
…, CA Scherer, DG Miner, MG Katze, SP Iadonato - Genome biology, 2005 - Springer
We report the initial sequencing and comparative analysis of the Macaca mulatta transcriptome.
Cloned sequences from 11 tissues, nine animals, and three species (M. mulatta, M. …
Cloned sequences from 11 tissues, nine animals, and three species (M. mulatta, M. …
Isoflavone agonists of IRF-3 dependent signaling have antiviral activity against RNA viruses
…, YM Loo, MG Katze, M Gale Jr, SP Iadonato - Journal of …, 2012 - Am Soc Microbiol
There is a growing need for novel antiviral therapies that are broad spectrum, effective, and
not subject to resistance due to viral mutations. Using high-throughput screening methods, …
not subject to resistance due to viral mutations. Using high-throughput screening methods, …
[HTML][HTML] A potent Lassa virus antiviral targets an arenavirus virulence determinant
…, MJ Korth, KM Bedard, SP Iadonato… - PLoS …, 2018 - journals.plos.org
Arenaviruses are a significant cause of hemorrhagic fever, an often-fatal disease for which
there is no approved antiviral therapy. Lassa fever in particular generates high morbidity and …
there is no approved antiviral therapy. Lassa fever in particular generates high morbidity and …